| Schwabe Pharma AG - Tebokan 120, Filmtabletten | | 54534 | | 03 | | Tebokan 120 | | Filmtabletten | | N06DX02 | | Ginkgo biloba | | 07.02.2007 | | |
| | Composition | | ginkgonis extractum siccum raffinatum et quantificatum (Ginkgo biloba L., folium) 120 mg corresp. flavonglycosida ginkgo 26.4-32.4 mg, ginkgolidae A, B et C 3.36-4.08 mg et bilobalidum 3.12-3.84 mg, DER: 35-67:1, Auszugsmittel acetonum 60% (m/m), lactosum monohydricum 68.25 mg, cellulosum microcristallinum, maydis amylum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium 1.65 mg, magnesii stearas, Überzug: hypromellosum, macrogolum 1500, E 172 (flavum), E 171, talcum, simeticonum, silica colloidalis anhydrica, macrogoli 5 aether stearylicus, E 200, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Ginkgonis Extractum Siccum Raffinatum et Quantificatum (Ginkgo Biloba l., Folium) | 120 mg correspond Flavonglycosida Ginkgo 26.4-32.4 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Ginkgonis Extractum Siccum Raffinatum et Quantificatum | 120 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Aether Stearylicus | | | | Auszugsmittel Acetonum 60% (M/m) | | | | B | | | | Bilobalidum | 3.12-3.84 mg | | | C | 3.36-4.08 mg | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Der: 35-67:1 | | | | E 171 | | color. | | E 172 | | color. | | E 200 | | conserv. | | Ginkgolidae A | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 68.25 mg | | | Macrogoli | 5 | | | Macrogol | 1500 | | | Magnesii Stearas | | | | Maydis Amylum | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Simeticone | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 045 | 90 Comprimé(s) | 52.73 | 73.75 | B | LS | Oui | | 046 | 120 Comprimé(s) | 66.02 | 88.20 | B | LS | Oui |
|
|
